These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 16133140)

  • 1. Neurosteroids in nicotine and morphine dependence.
    Concas A; Sogliano C; Porcu P; Marra C; Brundu A; Biggio G
    Psychopharmacology (Berl); 2006 Jun; 186(3):281-92. PubMed ID: 16133140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
    Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
    Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic neurosteroid treatment prevents the development of morphine tolerance and attenuates abstinence behavior in mice.
    Reddy DS; Kulkarni SK
    Eur J Pharmacol; 1997 Oct; 337(1):19-25. PubMed ID: 9389376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine withdrawal hyperalgesia and opioid-mediated analgesia depend on nicotine receptors in nucleus accumbens.
    Schmidt BL; Tambeli CH; Gear RW; Levine JD
    Neuroscience; 2001; 106(1):129-36. PubMed ID: 11564423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tropisetron attenuates naloxone-induced place aversion in single-dose morphine-treated rats: role of alpha7 nicotinic receptors.
    Cui R; Suemaru K; Li B; Kohnomi S; Araki H
    Eur J Pharmacol; 2009 May; 609(1-3):74-7. PubMed ID: 19374878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats.
    Ise Y; Narita M; Nagase H; Suzuki T
    Psychopharmacology (Berl); 2000 Jul; 151(1):49-54. PubMed ID: 10958116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alpha4beta2 and alpha7 nicotinic acetylcholine receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats.
    Motoshima S; Suemaru K; Kawasaki Y; Jin C; Kawasaki H; Gomita Y; Araki H
    Eur J Pharmacol; 2005 Sep; 519(1-2):91-5. PubMed ID: 16098507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Subchronic Intravenous Morphine Infusion and Naloxone-Precipitated Morphine Withdrawal on P-gp and Bcrp at the Rat Blood-Brain Barrier.
    Chaves C; Gómez-Zepeda D; Auvity S; Menet MC; Crété D; Labat L; Remião F; Cisternino S; Declèves X
    J Pharm Sci; 2016 Jan; 105(1):350-8. PubMed ID: 26554626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone precipitates nicotine abstinence syndrome and attenuates nicotine-induced antinociception in mice.
    Biała G; Budzyńska B; Kruk M
    Pharmacol Rep; 2005; 57(6):755-60. PubMed ID: 16382193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-tolerance between morphine- and nicotine-induced conditioned place preference in mice.
    Zarrindast MR; Faraji N; Rostami P; Sahraei H; Ghoshouni H
    Pharmacol Biochem Behav; 2003 Jan; 74(2):363-9. PubMed ID: 12479956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of morphine dependence and withdrawal on levels of neurosteroids in rat brain.
    Yan CZ; Hou YN
    Acta Pharmacol Sin; 2004 Oct; 25(10):1285-91. PubMed ID: 15456529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis.
    Alcaraz C; Vargas ML; Milanés MV
    Neuropeptides; 1996 Feb; 30(1):29-36. PubMed ID: 8868296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
    Liu J; Schulteis G
    Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic mild stress on the development of drug dependence in rats.
    Papp M; Gruca P; Lason-Tyburkiewicz M; Litwa E; Willner P
    Behav Pharmacol; 2014 Sep; 25(5-6):518-31. PubMed ID: 24949570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferences for tastes paired with a nicotine antagonist in rats chronically treated with nicotine.
    Mucha RF
    Pharmacol Biochem Behav; 1997 Feb; 56(2):175-9. PubMed ID: 9050072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L; Cador M; Zorrilla EP; Koob GF
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical 3 alpha-hydroxy-5 alpha-pregnan-20-one levels after acute administration of Delta 9-tetrahydrocannabinol, cocaine and morphine.
    Grobin AC; VanDoren MJ; Porrino LJ; Morrow AL
    Psychopharmacology (Berl); 2005 May; 179(3):544-50. PubMed ID: 15619118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine attenuates place aversion induced by naloxone in single-dose, morphine-treated rats.
    Araki H; Kawakami KY; Jin C; Suemaru K; Kitamura Y; Nagata M; Futagami K; Shibata K; Kawasaki H; Gomita Y
    Psychopharmacology (Berl); 2004 Feb; 171(4):398-404. PubMed ID: 13680070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator.
    Singh P; Sharma B; Gupta S; Sharma BM
    Psychopharmacology (Berl); 2015 Jan; 232(2):465-75. PubMed ID: 25059539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of noradrenergic transmission in the PVN on CREB activation, TORC1 levels, and pituitary-adrenal axis activity during morphine withdrawal.
    Martín F; Núñez C; Marín MT; Laorden ML; Kovács KJ; Milanés MV
    PLoS One; 2012; 7(2):e31119. PubMed ID: 22355339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.